Logo image of BSTG

Biostage Inc. (BSTG) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:BSTG -

0.23
-0.07 (-23.33%)
Last: 10/5/2017, 8:10:00 PM
0.25
+0.02 (+8.7%)
After Hours: 10/5/2017, 8:10:00 PM

BSTG Key Statistics, Chart & Performance

Key Statistics
Market Cap8.98M
Revenue(TTM)54.00K
Net Income(TTM)-13.84M
Shares39.03M
Float37.47M
52 Week High1.42
52 Week Low0.2
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-0.61
PEN/A
Fwd PEN/A
Earnings (Next)04-11
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
BSTG short term performance overview.The bars show the price performance of BSTG in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

BSTG long term performance overview.The bars show the price performance of BSTG in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of BSTG is 0.23 null. In the past month the price decreased by -25.32%. In the past year, price decreased by -75.53%.

Biostage Inc. / BSTG Daily stock chart

BSTG Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

BSTG Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to BSTG. BSTG may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BSTG Financial Highlights

Over the last trailing twelve months BSTG reported a non-GAAP Earnings per Share(EPS) of -0.614. The EPS increased by 7.92% compared to the year before.


Industry RankSector Rank
PM (TTM) -25627.78%
ROA -297.23%
ROE -1081.17%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%44.39%
Sales Q2Q%-100%
EPS 1Y (TTM)7.92%
Revenue 1Y (TTM)-26.03%

BSTG Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

BSTG Ownership

Ownership
Inst Owners0.03%
Ins Owners6.21%
Short Float %N/A
Short RatioN/A

About BSTG

Company Profile

Biostage, Inc. is a biotechnology company. It is engaged in developing bioengineered organ implants based on the company's new Cellframe (TM) technology to treat life-threatening conditions of the esophagus, trachea or bronchus. Biostage Inc., formerly known as Harvard Apparatus Regenerative Technology Inc., is based in HOLLISTON, Mass.

Company Info

Biostage Inc.

84 October Hill Road Suite 11

Holliston MA 01746

CEO: James McGorry

Phone: 774-233-7300

Biostage Inc. / BSTG FAQ

What does BSTG do?

Biostage, Inc. is a biotechnology company. It is engaged in developing bioengineered organ implants based on the company's new Cellframe (TM) technology to treat life-threatening conditions of the esophagus, trachea or bronchus. Biostage Inc., formerly known as Harvard Apparatus Regenerative Technology Inc., is based in HOLLISTON, Mass.


What is the current price of BSTG stock?

The current stock price of BSTG is 0.23 null. The price decreased by -23.33% in the last trading session.


What is the dividend status of Biostage Inc.?

BSTG does not pay a dividend.


How is the ChartMill rating for Biostage Inc.?

BSTG has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Where is Biostage Inc. (BSTG) stock traded?

BSTG stock is listed on the Nasdaq exchange.


How is the valuation of Biostage Inc. (BSTG) based on its PE ratio?

Biostage Inc. (BSTG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.61).


Would investing in Biostage Inc. be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BSTG.